| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michele A. Anderson | CXO | 2026-08-07 | 1,111 | $18.00 | $20.00kBuy |
| Forbion Growth Opportunities Fund III Cooperatief Ua | 10% Owner | 2026-08-07 | 1,920,000 | $18.00 | $34.56MBuy |
| Forbion Growth Opportunities Fund III Cooperatief Ua | 10% Owner | 2026-08-07 | 1,680,000 | $18.00 | $30.24MBuy |
| David Charles Lubner | Director | 2026-08-07 | 55,555 | $18.00 | $999.99kBuy |
| David I. Malek | Director | 2026-08-07 | 4,166 | $18.00 | $74.99kBuy |
| Travis Murdoch | CEO;Pres | 2026-08-07 | 83,333 | $18.00 | $1.50MBuy |
| James Paul Rickey | CFO | 2026-08-07 | 27,777 | $18.00 | $499.99kBuy |
| Christopher Viehbacher | Director | 2026-08-07 | 83,333 | $18.00 | $1.50MBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Forbion Growth Opportunities Fund III Cooperatief Ua | 30.89% | 21,826,024 | $654.78M | Insider |
| Travis Murdoch | 11.80% | 8,333,637 | $250.01M | Insider |
| Erez Chimovits | 1.56% | 1,102,739 | $33.08M | Insider |
| Orbimed Advisors LLC | 1.56% | 1,102,739 | $33.08M | Insider |
| Jason V. Coloma | 1.56% | 1,100,456 | $33.01M | Insider |
| David I. Malek | 1.43% | 1,013,297 | $30.40M | Insider |
| Christopher Viehbacher | 1.08% | 759,857 | $22.80M | Insider |
| James Paul Rickey | 1.00% | 703,575 | $21.11M | Insider |
| Michele A. Anderson | 0.47% | 332,161 | $9.96M | Insider |
| David Charles Lubner | 0.08% | 55,555 | $1.67M | Insider |